Envision Report

Published January 9, 2018

United Kingdom Neurology Devices Market – share, Outlook, Trends, Size and Forecasts (2018 – 2024)

Download Free Sample Report!

Neurology is a branch of medicine that deals with the disorders of the nervous system and also deals with the diagnosis and treatment of diseases involving central and peripheral nervous system. Neurological devices such as ventricular needles, neurostimulators, and blood clot retrievers can prevent neurological disorders and can be used to restore hearing and sight. The market share is estimated to reach USD XX billion with a CAGR of XX% by 2024.

UK Neurology Devices Market Share:

Compared to the past years, Neurology devices have undergone a predominant change in the markets of UK. The neurostimulation devices are expected to have the highest growth rate due to the increasing number of aging population, advancement in technology and growing demand for the medical procedures.

UK Neurology Devices Market Size:

There is wide range of fields in which these Neurology Devices are used such as Interventional Neurology Devices and this is subcategorized into Cerebral Balloon Devices, Neurothrombectomy Devices, and Neurosurgery Devices. As there are enormous applications, the market size related to Neurology Devices is even bigger in the UK.

UK Neurology Devices Market Growth:

The factors that drive the growth of the market are increasing in respiratory disease population, growing number of stroke and cerebral aneurysms cases and increasing disposable incomes coupled with a change in lifestyle. Tax reform is the main factor that prevents the growth of the market.

UK Neurology Devices Market Industry Analysis:

UK Neurology Devices Market is segmented on the basis of neurology devices which are further classified into interventional neurology devices, cerebral balloon devices, neuro thrombectomy devices, neurosurgery devices, aneurysm coiling & embolization and neurostimulation devices.

UK Neurology Devices Market Outlook:

Due to the growth of health consciousness among people, aging population, increase in hospital number, demand for the hospital supplies, the growth of different types of dreadful diseases has led hospital supplies to have a greater outlook where the market parameters and marginal values are taken into consideration.

 UK Neurology Devices Market Trends:

Immunocore has the T-Cell receptor technology that is used to treat cancer and autoimmune diseases. Chroma Therapeutics is building the preclinical pipeline of novel inflammation therapies.

UK Neurology Devices Market Research Report includes:

  • An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
  • To have complete market analysis through industry value chain analysisPorter’s fivePESTLESWOT analysis, and Y-o-Y analysis.
  • Regional and global diversity is analyzed with the major countries and the unions.
  • Scrutinizing the revenue generation on YearOnYear
  • Identifying DROC in the current market and their impact in altering the market dynamics.
  • Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
  • Expertise investment opportunities by an analyst to the individual and organization to have a better foothold in the market.
  • Identify the latest developments, market shares and strategies that are employed by the major market players, such as
  • Chroma Therapeutics
  • Immunocore
  • PsiOxus Therapeutics
  • Summit Therapeutics
  • Acumed

Chapter 1 Introduction

1.1 Executive Summary

1.2 Market Definition

1.3 Scope of the Study

Chapter 2 Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Analytic Tools and Model

2.4 Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5 Expert Validation

2.6 Study Timeline

Chapter 3 Market Analysis

3.1 Industry Value Chain Analysis

3.2 Porter’s Five Analysis

3.2.1 Bargaining Power of Buyers

3.2.2 Bargaining Power of Suppliers

3.2.3 Threats of Substitutes

3.2.4 Threats of New Entrants

3.2.5 Industry Rivalry

3.3 PESTLE Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4 SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threats

3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

Chapter 5 Market Segmentation Analysis

Chapter 6 Market Segmentation by Type

6.1 Neurology Devices
6.1.1 By Type of Device

6.1.1.1 Neurosurgery Devices

6.1.1.1.1 Neuroendoscopes

6.1.1.1.2 Stereotactic Systems

6.1.1.1.3 Aneurysm Clips

6.1.1.1.4 Ultrasonic Aspirators

6.1.1.2 Interventional Neurology Devices

6.1.1.2.1 Neurothrombectomy Devices

– Clot Retrievers

– Suction Aspiration Devices

– Snare Devices

6.1.1.2.2 Cerebral Balloon Devices

– Carotid Artery Stents

– Filter Devices

–  Balloon Occlusion Devices

6.1.1.2.3 Aneurysm Coiling & Embolization

– Embolic Coils

– Liquid Embolic Agents

– Flow Diversion Devices

6.1.1.2.4 Support Devices

6.1.1.3 Neurostimulation Devices

6.1.1.3.1 Spinal Cord Stimulation Devices

6.1.1.3.2 Deep Brain Stimulation Devices

6.1.1.3.3 Sacral Nerve Stimulation Devices

6.1.1.3.4 Vagus Nerve Stimulation Devices

6.1.1.3.5 Gastric Electric Stimulation Device

6.1.4.1 Cerebrospinal Fluid Management Devices

6.1.4.1.1 Cerebral Shunts

6.1.4.1.2 Cerebral External Drainage     

Chapter 7 Market Segmentation by Geography

7.1 UK

Chapter 8 Competitive Landscape

8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

8.2 Market Share Analysis

8.3 Strategies Adopted By Top Companies

Chapter 9 Company Profiles

9.1 Adaptimmune Therapeutics

9.1.1 Business Overview

9.1.2 Product portfolio

9.1.3 Key Strategy

9.1.4 Recent Developments

9.2 Chroma Therapeutics

9.3 Immunocore

9.4 PsiOxus Therapeutics

9.5 Summit Therapeutics

9.6 Acumed

9.7 Glaxo SmithKline

9.8 Recipharm

9.9 ProMetic Life Sciences

9.10 Teleflex Medical

9.11 The binding site

9.12 Cambridge Research Biochemicals

9.13 Biofortuna

9.14 DiscoveRx

9.15 Parexel

Chapter 10 Market Estimates and Forecast

10.1 Market Estimates and Forecast 2018-2024(USD Million)

10.1.1 Market Estimation and Forecast by Type 2018-2024 (USD Million)

10.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Million)

10.1.3 Market Estimates and Forecast by Company 2018-2024 ( USD Million)

Chapter 11 Market Insights

11.1 Insights of Industry Experts

11.2 Analyst Opinion (Market Understanding)

11.3 Investment Opportunities

Chapter 12 Appendix

12.1 List of Tables

12.2 List of Figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.

 

©2018 - Envision Inteligence | All Rights Reserved.